RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
@orthoandtrauma @zobobarroni
A la inversa de lo sugerido inicialmente los IECA y ARA II (“priles y sartanes”) se asocian a menor mortalidad por COVID 19. Como siempre, las hipótesis teóricas se arrodillan ante la evidencia empírica.
RT @paomorejon: Quedaría mejor si le cambiamos un poco❓❤️ “Al menos daño no hacen” Difícil llegar a esa conclusión al ser retrospectivo ob…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
papier de Circulation Research sur IEC/ARA2 et COVID https://t.co/36hyftxDR2
RT @FZores: Le fil est terminé 🔽 https://t.co/36hyftxDR2
Le fil est terminé 🔽
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
1128 hospitalized #COVID19 patients with #hypertension: Those on ACEI/ARB medication had lower all-cause mortality (3.7% vs 9.8%, adjusted HR 0.42) vs non-users of Angiotensin Converting Enzyme Inhibitors & Angiotensin II Receptor Blockers. https://t.c
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @DavidLBrownMD: Wow. Pre-Covid19 an article like this is in AJC. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitor…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @NightShiftMD: It might just block the pathway through which #COVID19 penetrates the lungs.
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @MartinQuirosMD: Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. L…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
ACEI / ARB not associated with increased mortality in Covid. Could even be protective according to this paper. https://t.co/2iHlhyrkYZ
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
Phew! Some good news for many of us!
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
This is good news for those of us 'taking the tablets'
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
C'est parti pour un fil sur cet article paru hier dans @CircRes Question posée : les IEC/ARA2 (traitement de l'hypertension et de l'insuffisance cardiaque) sont-ils ou non protecteurs dans la #COVID19 ? #COVID_fmc https://t.co/ENx8vgQaxx
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @rincondesisifo: (Circulation) Uso de IECA y ARA2 en pac con HTA y #COVID19 hospitalizados y riesgo de mortalidad https://t.co/iRkVpyypE…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @Dr_J_Underwood: Interesting data and adjusted analyses for once suggesting chronic use of ACEI /ARB may be associated with lower mortal…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
🛑Nuevos datos ACEI/ARB 🛑 📍Pts hypert 📍Retrospective 📍All-cause mort < in ACEI/ARB vs non-ACEI/ARB (adHR, 0.42; 95% CI, 0.19-0.92) 📍Propensity score-matched analysis ⬇️ mortality (adHR, 0.30; 95%CI, 0.12-0.70) #covidjournalclub #COVID19 https://t.co/Q6
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
Pequeños pasos, grandes logros. ✨❤️ Mantengamos la esperanza, este virus es fuerte, pero nuestra esperanza lo es más. Ánimo y gracias por esa labor constante de desentrañar enigmas. ¡Saldremos de esto!
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
@somersetstroke
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
An infographic on the latest update on the use of ACEIs and ARBs in hypertensive patients with COVID-19 from @American_Heart Read the study: https://t.co/5ytr3RInf0 #coronavirus #COVID19 #research https://t.co/NRGvObWdjA
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @Jennifercarryer: Trish Greenhalgh is an international treasure with her consistent rigorous attention to evidence and her accessible me…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @Dr_J_Underwood: Interesting data and adjusted analyses for once suggesting chronic use of ACEI /ARB may be associated with lower mortal…